Somerset Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-21,287
| Closed | -$516K | – | 186 |
|
|
2025
Q2 | $516K | Sell |
21,287
-2,167
| -9% | -$50.5K | 0.17% | 100 |
|
|
2025
Q1 | $594K | Buy |
23,454
+1,933
| +9% | +$50.6K | 0.21% | 77 |
|
|
2024
Q4 | $571K | Sell |
21,521
-16,475
| -43% | -$447K | 0.21% | 78 |
|
|
2024
Q3 | $1.1M | Sell |
37,996
-202
| -0.5% | -$5.89K | 0.41% | 56 |
|
|
2024
Q2 | $1.07M | Buy |
38,198
+332
| +0.9% | +$9.14K | 0.44% | 53 |
|
|
2024
Q1 | $1.05M | Sell |
37,866
-1,502
| -4% | -$41.7K | 0.43% | 54 |
|
|
2023
Q4 | $1.13M | Sell |
39,368
-1,415
| -3% | -$42.8K | 0.5% | 51 |
|
|
2023
Q3 | $1.35M | Sell |
40,783
-2,682
| -6% | -$94.8K | 0.62% | 46 |
|
|
2023
Q2 | $1.59M | Sell |
43,465
-1,924
| -4% | -$74.9K | 0.69% | 46 |
|
|
2023
Q1 | $1.85M | Sell |
45,389
-4,931
| -10% | -$213K | 0.8% | 45 |
|
|
2022
Q4 | $2.58M | Sell |
50,320
-323
| -0.6% | -$15.5K | 1.08% | 40 |
|
|
2022
Q3 | $2.22M | Sell |
50,643
-512
| -1% | -$24.9K | 1.03% | 38 |
|
|
2022
Q2 | $2.68M | Sell |
51,155
-118
| -0.2% | -$6.01K | 1.18% | 35 |
|
|
2022
Q1 | $2.65M | Sell |
51,273
-593
| -1% | -$30.8K | 1.03% | 40 |
|
|
2021
Q4 | $3.06M | Buy |
51,866
+69
| +0.1% | +$3.42K | 1.12% | 37 |
|
|
2021
Q3 | $2.23M | Buy |
51,797
+3,517
| +7% | +$156K | 0.91% | 42 |
|
|
2021
Q2 | $1.89M | Buy |
48,280
+12
| +0% | +$467 | 0.77% | 47 |
|
|
2021
Q1 | $1.75M | Sell |
48,268
-212
| -0.4% | -$7.53K | 0.75% | 48 |
|
|
2020
Q4 | $1.78M | Sell |
48,480
-2,131
| -4% | -$78.2K | 0.81% | 47 |
|
|
2020
Q3 | $1.76M | Sell |
50,611
-86
| -0.2% | -$3.02K | 0.89% | 45 |
|
|
2020
Q2 | $1.57M | Buy |
50,697
+23
| +0% | +$781 | 0.84% | 47 |
|
|
2020
Q1 | $1.57M | Sell |
50,674
-6,795
| -12% | -$232K | 1.03% | 42 |
|
|
2019
Q4 | $2.14M | Sell |
57,469
-888
| -2% | -$31.6K | 1.06% | 39 |
|
|
2019
Q3 | $1.99M | Sell |
58,357
-8,310
| -12% | -$302K | 1.05% | 39 |
|
|
2019
Q2 | $2.74M | Sell |
66,667
-983
| -1% | -$39K | 1.41% | 23 |
|
|
2019
Q1 | $2.73M | Hold |
67,650
| – | – | 1.43% | 20 |
|
|
2018
Q4 | $2.8M | Sell |
67,650
-1,003
| -1% | -$41.6K | 1.63% | 14 |
|
|
2018
Q3 | $2.87M | Sell |
68,653
-241
| -0.3% | -$9.28K | 1.42% | 19 |
|
|
2018
Q2 | $2.37M | Sell |
68,894
-4,702
| -6% | -$161K | 1.27% | 18 |
|
|
2018
Q1 | $2.48M | Sell |
73,596
-864
| -1% | -$29.7K | 1.28% | 19 |
|
|
2017
Q4 | $2.56M | Sell |
74,460
-3,307
| -4% | -$113K | 1.28% | 19 |
|
|
2017
Q3 | $2.63M | Sell |
77,767
-5,444
| -7% | -$175K | 1.4% | 14 |
|
|
2017
Q2 | $2.65M | Sell |
83,211
-1,028
| -1% | -$32.4K | 1.45% | 15 |
|
|
2017
Q1 | $2.73M | Sell |
84,239
-1,728
| -2% | -$54.5K | 1.53% | 14 |
|
|
2016
Q4 | $2.65M | Sell |
85,967
-4,337
| -5% | -$132K | 1.57% | 12 |
|
|
2016
Q3 | $2.9M | Sell |
90,304
-11,315
| -11% | -$378K | 1.73% | 9 |
|
|
2016
Q2 | $3.39M | Buy |
101,619
+11,935
| +13% | +$381K | 2.1% | 6 |
|
|
2016
Q1 | $2.52M | Sell |
89,684
-383
| -0.4% | -$10.9K | 1.67% | 9 |
|
|
2015
Q4 | $2.76M | Buy |
90,067
+103
| +0.1% | +$3.24K | 1.81% | 6 |
|
|
2015
Q3 | $2.68M | Buy |
89,964
+679
| +0.8% | +$21.8K | 1.88% | 5 |
|
|
2015
Q2 | $2.84M | Sell |
89,285
-27
| -0% | -$880 | 1.86% | 4 |
|
|
2015
Q1 | $2.95M | Sell |
89,312
-403
| -0.4% | -$12.8K | 1.95% | 5 |
|
|
2014
Q4 | $2.65M | Sell |
89,715
-595
| -0.7% | -$17.1K | 1.76% | 13 |
|
|
2014
Q3 | $2.53M | Sell |
90,310
-1,188
| -1% | -$33.3K | 1.77% | 12 |
|
|
2014
Q2 | $2.58M | Sell |
91,498
-891
| -1% | -$25.4K | 1.83% | 11 |
|
|
2014
Q1 | $2.81M | Buy |
92,389
+9,108
| +11% | +$272K | 2.14% | 7 |
|
|
2013
Q4 | $2.42M | Buy |
+83,281
| New | +$2.42M | 1.84% | 10 |
|
Other funds holding PFE
Somerset Trust's PFE Position: Q3 2025 in Review
Somerset Trust sold out of Pfizer (PFE) in Q3 2025, closing a stake of 21,287 shares — an estimated $516K sold.
Somerset Trust first reported a position in PFE in Q4 2013 and held it in 47 quarters. The position peaked at $3.39M in Q2 2016. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Somerset Trust reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Somerset Trust sold 21,287 Pfizer shares in Q3 2025, an estimated $516K.
- Somerset Trust first reported a position in Pfizer in Q4 2013 and held it in 47 quarters.
- Somerset Trust's Pfizer position peaked at $3.39M in Q2 2016.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Somerset Trust's 13F filing for Q3 2025, filed 14 Oct 2025.